Arcturus Therapeutics
(NASDAQ) ARCT
Arcturus Therapeutics Financials at a Glance
Market Cap
$237.62M
Revenue (TTM)
$74.12M
Net Income (TTM)
$65.78M
EPS (TTM)
$-2.39
P/E Ratio
-3.50
Dividend
$0.00
Beta (Volatility)
1.98 (High)
Dividend
$0.00
Beta (Volatility)
1.98 (High)
Price
$8.36
Volume
14,623
Open
$8.37
Price
$8.36
Volume
14,623
Open
$8.37
Previous Close
$8.36
Daily Range
$8.19 - $8.42
52-Week Range
$5.85 - $24.17
Dividend
$0.00
Beta (Volatility)
1.98 (High)
Price
$8.36
Volume
14,623
Open
$8.37
Previous Close
$8.36
Daily Range
$8.19 - $8.42
52-Week Range
$5.85 - $24.17
ARCT News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Arcturus Therapeutics
Industry
Biotechnology
Sector
Health CareEmployees
111
CEO
Joseph E. Payne
Website
www.arcturusrx.comHeadquarters
San Diego, CA 92121, US
ARCT Financials
Key Financial Metrics (TTM)
Gross Margin
95%
Operating Margin
-1%
Net Income Margin
-89%
Return on Equity
-29%
Return on Capital
-32%
Return on Assets
-24%
Earnings Yield
-28.57%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$237.62M
Shares Outstanding
28.42M
Volume
14.62K
Short Interest
0.00%
Avg. Volume
506.09K
Financials (TTM)
Gross Profit
$64.20M
Operating Income
$74.95M
EBITDA
$71.93M
Operating Cash Flow
$74.27M
Capital Expenditure
$230.00K
Free Cash Flow
$74.27M
Cash & ST Invst.
$230.91M
Total Debt
$25.00M
Arcturus Therapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$3.08M
-85.3%
Gross Profit
$2.40M
-88.6%
Gross Margin
77.86%
N/A
Market Cap
$237.62M
N/A
Market Cap/Employee
$1.37M
N/A
Employees
174
N/A
Net Income
$29.08M
+3.1%
EBITDA
$32.16M
-10.2%
Quarterly Fundamentals
Net Cash
$205.91M
-1.2%
Accounts Receivable
$5.56M
+40.0%
Inventory
$0.00
N/A
Long Term Debt
$20.78M
-16.9%
Short Term Debt
$4.21M
+18.6%
Return on Assets
-24.26%
N/A
Return on Invested Capital
-31.93%
N/A
Free Cash Flow
$16.36M
-5662.2%
Operating Cash Flow
$16.23M
-5613.7%